MLO LABline Daily - Mar 2nd, 2024
 
 
MLO LABline Daily | View online
 
March 2, 2024
Sponsored

Our Novaplex™ respiratory panel assays can test for the most prevalent respiratory pathogens including bacteria and viruses, across multiple sample types. For research use only.

A new prostate cancer resource - the Prostate Cancer Outcomes Report Card - hopes to make it easier for men and their families to better understand the treatment options and outcomes.
Sponsored

MAKING MODERN LABS MORE: more efficient, more productive, more profitable. Polytech is premium customized laboratory information software that provides complete lab automation integration and total data management with specialized molecular, pathology, toxicology, microbiology, PGx, billing and reports modules.

The World Health Organization (WHO) announced the recommendations for the viral composition of influenza vaccines for the 2024-2025 influenza season in the northern hemisphere.
A team of Michigan State University scientists has unveiled a potential game-changer in the fight against glioblastoma.
A study led by Johns Hopkins Children’s Center shows omalizumab — an injectable, Food and Drug Administration (FDA)-approved medication for treating asthma and other allergic conditions — substantially reduced potentially life-threatening reactions in patients with an allergy to peanut and other common...
The World Health Organization (WHO) announced US$ 4 million in funding from donors to create a catalytic grant fund for organizations working in pathogen genomic surveillance.
HOT CLIPS

Your March 2024 issue of MONTHLY MAGAZINE is now available online. View >>

SUBSCRIBE to more leading edge content from our digital edition!

CLR - Annual Buyer's Guide